Q3 2019 13F Holders as of 9/30/2019
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
119M
-
Number of holders
-
137
-
Total 13F shares, excl. options
-
42.7M
-
Shares change
-
+700K
-
Total reported value, excl. options
-
$486M
-
Value change
-
+$8.02M
-
Put/Call ratio
-
0.09
-
Number of buys
-
67
-
Number of sells
-
-41
-
Price
-
$11.38
Significant Holders of CYTOKINETICS INC - COMMON STOCK (CYTK) as of Q3 2019
153 filings reported holding CYTK - CYTOKINETICS INC - COMMON STOCK as of Q3 2019.
CYTOKINETICS INC - COMMON STOCK (CYTK) has 137 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 42.7M shares
of 119M outstanding shares and own 35.8% of the company stock.
Largest 10 shareholders include BlackRock Inc. (9.27M shares), VANGUARD GROUP INC (4.31M shares), BVF INC/IL (4.17M shares), DRIEHAUS CAPITAL MANAGEMENT LLC (2.72M shares), WASATCH ADVISORS INC (2.46M shares), STATE STREET CORP (2.32M shares), MILLENNIUM MANAGEMENT LLC (1.99M shares), Foresite Capital Management IV, LLC (1.9M shares), FEDERATED INVESTORS INC /PA/ (931K shares), and RP Management, LLC (876K shares).
This table shows the top 137 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.